title: Effect of angiotensin-converting enzyme inhibitor dosing interval on functional parameters in patients with chronic heart failure.
authors.affiliation: Monash University, Alfred Hospital, Prahran, Victoria, Australia.
authors.forename: H
authors.initials: H
authors.lastname: Krum
authors.forename: J
authors.initials: J
authors.lastname: Karrasch
authors.forename: A
authors.initials: A
authors.lastname: Hamer
authors.forename: D
authors.initials: D
authors.lastname: Hare
authors.forename: L G
authors.initials: LG
authors.lastname: Howes
authors.forename: B
authors.initials: B
authors.lastname: Jackson
authors.forename: P
authors.initials: P
authors.lastname: Leslie
mesh_terms: D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D018592:Cross-Over Studies; D004334:Drug Administration Schedule; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D007546:Isoquinolines / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D008297:Male; D000077583:Quinapril; D044005:Tetrahydroisoquinolines
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D007546:Isoquinolines; D044005:Tetrahydroisoquinolines; D000077583:Quinapril